Page 174 - 2022_01-Haematologica-web

T. Wang et al.
induced DNA damage. J Cell Physiol.
2009;221(3):594-602.
22.Clark DW, Mitra A, Fillmore RA, et al.
NUPR1 interacts with p53, transcriptional- ly regulates p21 and rescues breast epithe- lial cells from doxorubicin-induced geno- toxic stress. Curr Cancer Drug Targets. 2008;8(5):421-430.
23. Dumble M, Moore L, Chambers SM, et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 2007;109(4):1736-1742.
24. Lotem J, Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood. 1993;82(4):1092-1096.
25. Shounan Y, Dolnikov A, MacKenzie KL, Miller M, Chan YY, Symonds G. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia. 1996;10(10):1619-1628.
26. Bondar T, Medzhitov R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell. 2010;6(4):309- 322.
27. Liu Y, Elf SE, Miyata Y, et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell. 2009;4(1):37-48.
28. Chen J, Ellison FM, Keyvanfar K, et al. Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detec- tion of hematopoietic stem cell function in normal and Trp53 null mice. Exp Hematol. 2008;36(10):1236-1243.
29. Wang YV, Leblanc M, Fox N, et al. Fine-tun- ing p53 activity through C-terminal modifi- cation significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev. 2011;25(13):1426-1438.
30. Liu D, Ou L, Clemenson GD Jr, et al. Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol. 2010;12(10):993-998.
31. Yamashita M, Nitta E, Suda T. Regulation of hematopoietic stem cell integrity through p53 and its related factors. Ann N Y Acad Sci. 2016;1370(1):45-54.
32. Wilkinson AC, Ishida R, Kikuchi M, et al. Long-term ex vivo haematopoietic-stem- cell expansion allows nonconditioned transplantation. Nature. 2019;571(7763): 117-121.
33. Yamamoto R, Morita Y, Ooehara J, et al. Clonal analysis unveils self-renewing line- age-restricted progenitors generated direct- ly from hematopoietic stem cells. Cell. 2013;154(5):1112-1126.
34. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1-2):70-78.
35. Kiel MJ, He S, Ashkenazi R, et al. Haematopoietic stem cells do not asym- metrically segregate chromosomes or retain BrdU. Nature. 2007;449(7159):238- 242.
36.Motoda L, Osato M, Yamashita N, et al. Runx1 protects hematopoietic stem/prog- enitor cells from oncogenic insult. Stem Cells. 2007;25(12):2976-2986.
37. Miyamoto K, Araki KY, Naka K, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 2007;1(1):101-112.
38. Ficara F, Murphy MJ, Lin M, Cleary ML. Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell. 2008;2(5):484-496.
39. Tipping AJ, Pina C, Castor A, et al. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood. 2009;113(12):2661-2672.
40. Campbell TB, Basu S, Hangoc G, Tao W, Broxmeyer HE. Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation. Blood. 2009;114(16):3392- 3401.
41. Stobbe CC, Park SJ, Chapman JD. The radi- ation hypersensitivity of cells at mitosis. Int J Radiat Biol. 2002;78(12):1149-1157.
42. Yu H, Shen H, Yuan Y, et al. Deletion of Puma protects hematopoietic stem cells
and confers long-term survival in response to high-dose gamma-irradiation. Blood. 2010;115(17):3472-3480.
43. Hao S, Chen C, Cheng T. Cell cycle regula- tion of hematopoietic stem or progenitor cells. Int J Hematol. 2016;103(5):487-497.
44. Pietras EM, Warr MR, Passegue E. Cell cycle regulation in hematopoietic stem cells. J Cell Biol. 2011;195(5):709-720.
45. Li T, Kon N, Jiang L, et al. Tumor suppres- sion in the absence of p53-mediated cell- cycle arrest, apoptosis, and senescence. Cell. 2012;149(6):1269-1283.
46. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420(1):25-27.
47.
Abbas HA, Maccio DR, Coskun S, et al. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell. 2010;7(5):606-617.
48. Anthony BA, Link DC. Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol. 2014;35(1): 32-37.
49. Challen GA, Sun D, Mayle A, et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell. 2014;15(3):350-364.
50. Young JH, Logan BR, Wu J, et al. Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated eonors. Biol Blood Marrow Transplant. 2016;22(2):359-370.
51. Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis. 2011;53(8):798-806.
52. Orazi A, Kahsai M, John K, Neiman RS. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. Mod Pathol. 1996;9(1):48-52.
53. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387(6630):296-299.
166
haematologica | 2022; 107(1)